BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 20179432)

  • 1. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine smooth-muscle tumors with unusual growth patterns.
    Vaquero ME; Magrina JF; Leslie KO
    J Minim Invasive Gynecol; 2009; 16(3):263-8. PubMed ID: 19423058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Bodner-Adler B; Bartl M; Wagner G
    Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
    Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
    Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
    Quade BJ
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
    Ip PP; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
    Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
    Shi YF; Xie X; Zhao CL
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
    Burns B; Curry RH; Bell ME
    Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
    Lee HJ; Choi J; Kim KR
    Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
    Bell SW; Kempson RL; Hendrickson MR
    Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.